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Antibacterial activityAbstract 3-Amino-5-phenyl-2-ethoxycarbonylthieno[2,3-c]pyridazine (6) was prepared by reaction
of 4-cyano-6-phenylpyridazine-3(2H)-thione (4) with ethyl chloroacetate in the presence of sodium
ethoxide. Hydrazinolysis of compound 6 yielded the corresponding carbohydrazide, (9) which on
treatment with acetylacetone and ethyl acetoacetate produced the novel thieno[2,3-c]pyridazines
(10 and 11). Treatment of compound 9 with nitrous acid yielded the corresponding carboazide
(13), which upon boiling in toluene furnished imidazo[40,50:4,5]thieno[2,3-c]pyridazine (15). Pyri-
midothienopyridazines (16–18) were achieved by cyclocondensation of compound 9 with some
reagents, namely acetic anhydride, formic acid, and triethyl orthoformate. The newly synthesized
compounds were conﬁrmed by elemental analyses and spectral data. The antibacterial activities
of the new compounds were also evaluated.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Several thienopyridazines are known to possess a broad spec-
trum of biological activities. Some of them, for example, have
been evaluated pharmacologically andused for potent and selec-
tive phosphodiesterase IV inhibitor (Dal Piaz et al., 1997, 1998),
immunosuppressants (Bantick et al., 1999), antitumor (Dumas
et al., 2001), modules of protein tyrosine phosphatases (PT-
Pases) (Andersen et al., 1999), antimicrobials (Somoza et al.,
1998), blood platelet aggregation inhibitors (Iwase et al.,
1993), antibacterial (Abbady and Radwan, 1994) and antiviral
776 A.S.N. Al-Kamali et al.activity (Bundy et al., 2002). In view of the above observations
and as a continuation of our ongoing program directed to the
synthesis of heterocyclic systems containing thienopyridazine
moiety (Al-Kamali, 2009; Al-Kamali et al., 2009; Kamal El-
Dean and Al-Kamali, 2009), we report herein, the synthesis of
some new thieno[2,3-c]pyridazines, imidazothienopyridazine
and pyrimidothienopyridazines and their evaluation regarding
antibacterial activity by using 4-cyano-6-phenylpyridazine-
3(2H)-thione (4) as a starting material.2. Experimental
2.1. Materials and methods
Melting points were determined on an Electrothermal 9200
apparatus and are uncorrected. The reactions were monitored
by thin layer chromatography (TLC) on a silica coated alumi-
num sheet. The eluent was a mixture of dichloromethane and
methanol in different proportions. IR spectra were recorded
on a Shimadzu 470 IR spectrophotometer using KBr pellets.
1H NMR spectra were measured on a Varian 300 MHz
NMR spectrometer using TMS as the internal standard (d in
ppm). The mass spectra were recorded on a Jeol-JMS-600
apparatus. The UV spectrum was recorded on a Shimadzu
mini-1240 Spectrophotometer. Elemental analyses were per-
formed on a Perkin-Elmer 240 C microanalyzer.
2.2. Synthesis of 4-cyano-6-phenylpyridazine-3(2H)-thione (4)
A solution of compound 3 (0.01 mol) and thiourea (0.012 mol) in
ethanol (20 mL) was heated under reﬂux for 4 h, the precipitate
was boiled with 10% sodium hydroxide (5 mL) for 1 h. The solid
product was dissolved in water and acidiﬁed with 2 N hydrochlo-
ric acid. The solid product was ﬁltered off and recrystallized from
ethanol to afford compound 4 as brown crystals in 89% yield;
m.p. 206 C. IR: m= 3470 cm1 (NH), 2222 cm1 (C„N),
1230 cm1 (C‚S); UV 324 nm (C‚S); 1H NMR (DMSO-d6):
d 7.4–8.7 (m, 6H, Ar–H and pyridazine–H), 11.10 (broad, 1H,
NH). Anal. Calcd. for C11H7N3S (213.26): C, 61.95; H, 3.31; N,
19.70; S, 15.03. Found: C, 61.99; H, 3.27; N, 19.73; S, 15.01%.
2.3. Synthesis of 4-cyano-3-ethoxycarbonylmethylthio-6-
phenylpyridazine (5)
A mixture of compound 4 (0.01 mol), fused sodium acetate
(0.012 mol) and ethyl chloroacetate (0.01 mol) in ethanol
(50 mL) was stirred for 2 h. The solid product was ﬁltered off
and recrystallized from ethanol to give compound 5 as white
crystals in 67% yield; m.p. 140 C. IR: m= 2220 cm1
(C„N), 1720 cm1 (C‚O); 1H NMR (CDCl3): d 1.3 (t, 3H,
CH3), 4.2–4.3 (m, 4H, SCH2 and OCH2), 7.5–8.0 (m, 6H, Ar–
H and pyridazine–H). Anal. Calcd. for C15H13N3O2S (299.35):
C, 60.19; H, 4.38; N, 14.04; S, 10.71. Found: C, 60.10; H,
4.35; N, 14.11; S, 10.80%.
2.4. Synthesis of 3-amino-5-phenyl-2-ethoxycarbonylthieno[2,3-
c]pyridazine (6)
2.4.1. Method A
A mixture of compound 3 or 4 (0.01 mol) and ethylthioglyco-
late/sodium carbonate or ethyl chloroacetate (0.01 mol) in eth-anol (50 mL) containing sodium ethoxide (0.012 mol) was
reﬂuxed for 3 h. After cooling the solid product was collected
and recrystallized from ethanol–chloroform (9:1) to afford
compound 6 as yellow crystals in 93% yield: m.p. 225 C.
IR: m= 3430, 3300 cm1 (NH2), 1670 cm
1 (C‚O); 1H
NMR (DMSO-d6): d 1.3 (t, 3H, CH3), 4.3 (q, 2H, OCH2),
7.4–8.2 (m, 6H, Ar–H and pyridazine–H), 9.0 (s, 2H, NH2);
MS: m/z 299 (M+, 100%), 271 (7.61%), 253 (69.80%), 226
(6.00%), 77 (15.83%), 51 (13.65%). Anal. Calcd. for
C15H13N3O2S (299.35): C, 60.19; H, 4.38; N, 14.04; S, 10.71.
Found: C, 59.90; H, 4.50; N, 14.25; S, 10.67%.
2.4.2. Method B
A mixture of compound 5 (0.01 mol), substituted anilines
(0.01 mol) and sodium ethoxide (0.01 mol) in ethanol (50 mL)
was heated under reﬂux for 2 h. The solid product was collected
and recrystallized from ethanol–chloroform (9:1) to give
compound 6 as yellow crystals in 93% yield: m.p. 225 C.
The product was identical with that reported in method A.
2.5. Synthesis of 4-cyano-6-phenyl(pyridazin-3-yl-
thio)acetichydrazide (8)
A mixture of compound 5 (0.01 mol) and hydrazine hydrate
(0.01 mol) in ethanol (20 mL) was stirred for 3 h. The solid pre-
cipitate was collected by ﬁltration and recrystallized from eth-
anol–chloroform (9:1) to give compound 8 as yellow crystals
in 91% yield: m.p. 242 C. IR: m= 3400, 3290, 3200 cm1
(NH, NH2), 2230 cm
1 (C„N), 1680 cm1 (C‚O); 1H NMR
(DMSO-d6): d 4.1 (s, 2H, SCH2), 4.5 (s, 2H, NH2), 7.4–8.1
(m, 6H, Ar–H and pyridazine–H), 9.0 (s, 1H, NH).Anal. Calcd.
for C13H11N5OS (285.32): C, 54.73; H, 3.89; N, 24.55; S, 11.24.
Found: C, 54.68; H, 3.82; N, 24.62; S, 11.28%.
2.6. Synthesis of 3-amino-5-phenylthieno[2,3-c]pyridazine-2-
carbohydrazide (9)
2.6.1. Method A
A mixture of compound 5 or 6 (0.01 mol) and hydrazine
hydrate (0.01 mol) in ethanol (50 mL) was reﬂuxed for 3 h,
and then allowed to cool. The solid product was collected
and recrystallized from ethanol to give compound 9 as yellow
crystals in 93% yield: m.p. 298 C. IR: m= 3400, 3290,
3180 cm1 (NH, NH2), 1600 cm
1 (C‚O); MS: m/z 285
(M+, 62.59%), 270 (2.36%), 254 (100%), 77 (15.83%), 51
(13.65%). Anal. Calcd. for C13H11N5OS (285.32): C, 54.73;
H, 3.89; N, 24.55; S, 11.24. Found: C, 54.77; H, 3.93; N,
24.48; S, 11.15%.
2.6.2. Method B
A mixture of compound 8 (0.01 mol) and anhydrous potas-
sium carbonate (0.012 mol) in ethanol (30 mL) was heated
under reﬂux for 4 h. The solid product was collected and
recrystallized from ethanol to give compound 9 as yellow crys-
tals in 93% yield: m.p. 298 C.
2.7. Synthesis of 5-amino-3-phenyl-thieno[2,3-c]pyridazin-6-yl-
(3,5-dimethyl-pyrazol-1-yl)-ketone (10)
A mixture of carbohydrazide (9) (0.01 mol) and acetylacetone
(0.01 mol) in ethanol (10 mL) was heated under reﬂux for
about 4 h. The precipitate was ﬁltered off and recrystallized
Synthesis and antibacterial activity of some novel 777from ethanol to give compound 10 as orange crystals in 86%
yield: m.p. 288 C. IR: m= 3420, 3280 cm1 (NH2), 1680 cm1
(C‚O); 1H NMR (DMSO-d6): d 2.3, 2.6 (2s, 6H, 2CH3), 6.2
(s, 1H, pyrazole–H), 7.4–8.1 (m, 6H, Ar–H and pyridazine–
H), 9.0 (s, 2H, NH2); MS: m/z 349 (M
+, 92.70), 253
(100%), 95 (12.39%). Anal. Calcd. for C18H15N5OS (349.41):
C, 61.88; H, 4.33; N, 20.04; S, 9.18. Found: C, 61.88; H,
4.30; N, 20.01; S, 9.14%.
2.8. Synthesis of 5-amino-3-phenyl-6-ethylacetoacetatecarbo-
hydrazone-thieno[2,3-c]pyridazine (11)
A mixture of compound 9 (0.01 mol) and ethyl acetoacetate
(0.01 mol) in ethanol (10 mL) was heated under reﬂux for
3 h. The solid product was collected and recrystallized from
ethanol to give compound 11 as yellow crystals in 82% yield:
m.p. 265 C. IR: m= 3410, 3290 cm1 (NH2), 3190 cm1
(NH), 1720 cm1 (C‚O, ester), 1680 cm1 (C‚O); 1H
NMR (DMSO-d6): d 1.2 (t, 3H, CH3 of ester), 2.0 (s, 3H,
CH3), 3.4 (s, 2H, CH2), 4.1 (q, 2H, OCH2), 6.1 (s, 2H,
NH2), 7.5–8.3 (m, 6H, Ar–H and pyridazine–H), 9.1 (s, 1H,
NH). Anal. Calcd. for C19H19N5O3S (397.45): C, 57.42; H,
4.82; N, 17.62; S, 12.08. Found: C, 57.48; H, 4.85; N, 17.57;
S, 12.06%.
2.9. Synthesis of 3-amino-5-phenylthieno[2,3-c]pyridazine-2-
carboazide (13)
A sample of carbohydrazide (9) (0.01 mol) in glacial acetic acid
(10 mL), solution of sodium nitrite (0.015 mol in 3 mL H2O)
was added dropwise, then allowed to stand for 2 h. The solid
product was collected to give compound 13 as orange crystals
in 71% yield: m.p. 195 C (dec.). IR: m= 3400, 3280 cm1
(NH2), 2120 cm
1 (N3), 1620 cm
1 (C‚O); MS: m/z 296
(M+, 20.19%), 268 (30.67%), 253 (7.84%), 77 (38.98%), 51
(73.02%), 40 (100%). Anal. Calcd. for C13H8N6OS (296.31):
C, 52.70; H, 2.72; N, 28.36; S, 10.82. Found: C, 52.60; H,
2.74; N, 28.42; S, 10.91%.
2.10. Synthesis of 5-phenyl-1,3-dihydroimidazo[40,50:4,5]thieno-
[2,3-c]pyridazine-2-one (15)
Compound of carboazide (13) (0.01 mol) in dry toluene
(10 mL) was heated under reﬂux for 6 h, and then allowed to
cool. The solid product was collected and recrystallized from
ethanol to give compound 15 as light brown crystals in 70%
yield: m.p. >300 C. IR: m= 3200 cm1 (–NH–CO–NH–),
1704 cm1 (C‚O). Anal. Calcd. for C13H8N4OS (268.29): C,
58.20; H, 3.01; N, 20.88; S, 11.95. Found: C, 58.27; H, 3.03;
N, 20.90; S, 11.90%.
2.11. Synthesis of 7-acetylamino-6-methyl-3-
phenylpyrimido[40,50:4,5]thieno[2,3-c]pyridazin-8-one (16)
A mixture of compound 9 (0.01 mol) in acetic anhydride
(10 mL) was heated under reﬂux for 3 h, then allowed to cool,
and poured into water (50 mL).The solid product was collected
and recrystallized from ethanol to give compound 16 as white
crystals in 74% yield: m.p. 198 C. IR: m= 3300 cm1 (NH),
1710 cm1 (C‚O, acetyl), 1675 cm1 (C‚O, pyrimidinone);
1H NMR (DMSO-d6): d 2.16 (s, 3H, COCH3), 2.5 (s, 3H,
CH3), 7.4–8.3 (m, 6H, Ar–H and pyridazine–H), 11.3 (s, 1H,NH). Anal. Calcd. for C17H13N5O2S (351.38): C, 58.11; H,
3.73; N, 19.93; S, 9.12. Found: C, 58.06; H, 3.82; N, 19.91;
S, 9.09%.
2.12. Synthesis of 7-formylamino-3-phenylpyrimido[40,50:4,5]-
thieno[2,3-c]pyridazin-8-one (17)
A mixture of carbohydrazide (9) (0.01 mol) and formic acid
(10 mL) was heated under reﬂux for 3 h, then allowed to cool
and poured into water (50 mL). The formed product was col-
lected and recrystallized from ethanol to give compound 17 as
white crystals in 63% yield: m.p. 182 C. IR: m= 3270 cm1
(NH), at 1710 cm1 (C‚O, formyl), 1650 cm1 (C‚O); 1H
NMR (DMSO-d6): d 7.4–8.4 (m, 6H, Ar–H and pyridazine–
H), 8.6 (s, 1H, CHO), 8.8 (s, 1H, NH), 8.9 (s, 1H, pyrimi-
dine–H). Anal. Calcd. for C15H9N5O2S (323.33): C, 55.72; H,
2.81; N, 21.66; S, 9.92. Found: C, 55.76; H, 2.75; N, 21.70;
S, 9.94%.
2.13. Synthesis of 7-ethoxymethyleneamino-3-phenylpyrimido-
[40,50:4,5]thieno[2,3-c]pyridazin-8-one (18)
A mixture of carbohydrazide (9) (0.01 mol) and triethyl ortho-
formate (3 mL) in acetic anhydride (10 mL) was reﬂuxed for
3 h. The solid product was collected and recrystallized from
ethanol to give compound 18 as white crystals in 74% yield:
m.p. 230 C. IR: m= 1660 cm1 (C‚O, pyrimidinone),
1630 cm1 (C‚N); 1H NMR (DMSO-d6): d 1.4 (t, 3H,
CH3), 4.2 (q, 2H, OCH2), 7.3–8.4 (m, 7H, Ar–H, pyridazine–
H and pyrimidine–H), 9.1 (s, 1H, CH‚N). Anal. Calcd. for
C17H13N5O2S (351.38): C, 58.11; H, 3.73; N, 19.93; S, 9.12.
Found: C, 58.06; H, 3.81; N, 19.90; S, 9.07%.
2.14. Antibacterial activity
The compounds 4–6, 8–11, 16, and 17 were screened for their
antibacterial activity against the bacteria Staphylococcus xylo-
sus, Bacillus megaterium (Gram-positive bacteria), and Salmo-
nella typhii (Gram-negative bacteria) following the ﬁlter paper
disc technique. Ciproﬂoxacin was used as the standard anti-
bacterial agent. The synthesized compounds and Ciproﬂoxacin
were dissolved in DMSO at 25, 50, and 100 lg/disc concentra-
tions in nutrient agar media. Antibacterial activity was deter-
mined by measuring the diameter of the inhibition zone after
an incubation for 24 h at 37 C and the activity of each com-
pound was compared with Ciproﬂoxacin as a positive control.
The results are listed in Table 1. The antibacterial activity
showed that all compounds were active against microorgan-
isms. All compounds were less active in comparison to Cipro-
ﬂoxacin, which was taken as a standard drug. Further,
investigation on the biological activity of these compounds will
be considered in the progress.3. Results and discussion
The synthesis of the starting compound 4-cyano-6-phenylpy-
ridazine-3(2H)-thione (4) was performed from 4-carbethoxy-
6-phenylpyridazinone (1) by successive ammonolysis in
methanol to give 4-carboxamide-6-phenylpyridazine-3(2H)-
one (2). Treatment of the latter compound with phosphorous
oxychloride ensured both the dehydration of the carboxamide
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Table 1 Antibacterial screening results of the compounds 4–6,
8–11, 16, and 17.
Compound.
No.
Concentration
(lg/disc)
S.
xylosus
B.
megaterium
S.
typhii
4 25   
50   
100  + 
5 25  + 
50  + 
100 + + 
6 25   
50 +  
100 ++ + 
8 25 +  
50 + + 
100 + + 
9 25  + +
50  + +
100  + +
10 25   
50 + + 
100 + + 
11 25  + 
50  + 
100 + + ++
16 25  + 
50  + 
100 + + 
17 25  + 
50  + 
100  + 
Ciproﬂoxacin +++ +++ +++
Highly active =+++ (inhibition zone >27.9 mm).
Moderately active =++ (inhibition zone 18.7–27.9 mm).
Slightly active =+ (inhibition zone 9.4–18.6 mm).
Inactive =  (inhibition zone <9.3 mm).
778 A.S.N. Al-Kamali et al.function and the conversion of pyridazinone into 3-chloro-4-
cyano-6-phenylpyridazine (3). Compound 3 was subjected to
an addition–elimination reaction with thiourea in ethanol
under reﬂux for about 4 h, to afford compound 4 (Scheme 1).
Compounds 1–3 were obtained according to the reported
method (Wermuth et al., 1989) and the structures are in
agreement with the reported data. The structure of the new
compound 4 was established on the basis of elemental
analysis and spectral data. The IR spectrum of compound 4
showed absorption bands at 3470, 2220 and 1230 cm1 due
to imino, cyano and thiocarbonyl groups, respectively. 1H
NMR spectrum (DMSO-d6) of compound 4 showed a broad
singlet at d 11.1 ppm assigned to the NH and a multiplet at
d 7.4–8.7 ppm assigned to the phenyl protons and pyridazine
proton.
The reaction of compound 4 with ethyl chloroacetate in
reﬂuxing ethanol, in the presence of sodium acetate, yielded
3-ethoxycarbonylmethylthiopyridazine derivative (5). Thie-
no[2,3-c]pyridazine derivative (6) was achieved either by the
reaction of compound 3 with ethyl thioglycolate/sodium car-
bonate, or by the interaction of compound 4 with ethyl chloro-acetate in ethanol in the presence of sodium ethoxide. The
structure of compound 6 was established by another synthetic
route via cyclization of compound 5 with substituted anilines
in the presence of sodium ethoxide, instead, of the expected
compounds 7a–c (Scheme 2). The structure of compounds 5
and 6 was established by elemental analyses and spectral data.
The IR spectrum of compound 5 showed absorption bands at
2220 and 1720 cm1 could be attributed to cyano and ester
groups whilst, that the compound 6 displayed the disappear-
ance of cyano group and presence of the absorption bands
at 3430, 3300 and 1670 cm1 due to amino and carbonyl
groups, respectively. The 1H NMR spectrum of compound 6
in (DMSO-d6) showed a triplet at d 1.3 ppm, a quartet at d
4.3 ppm assigned to ethoxycarbonyl moiety in addition to
the aromatic and amino protons. Also, the structure of com-
pound 6 was conﬁrmed by the mass spectrum, which showed
that the molecular ion peak (base peak) at m/z= 299
(100%), which is in agreement with its molecular formula
(C15H13N3O2S).
Treatment of compound 5 with hydrazine hydrate in etha-
nol at room temperature for 3 h, afforded the corresponding 3-
methylthiocarbohydrazidepyridazine (8). However, carrying
the reaction under reﬂux gave the novel 2-carbohydrazidethie-
no[2,3-c]pyridazine derivative (9). Also, the latter compound
was obtained by reﬂuxing compound 5 or 6 with hydrazine
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Synthesis and antibacterial activity of some novel 779hydrate, or by compound 8 with potassium carbonate in etha-
nol (Scheme 3). The product compound 9 formed by the three
routes is identical in all respects (m.p., m.m.p., T.L.C., and
IR). The structure of the new compounds 8 and 9 was estab-
lished on the basis of their elemental analyses and spectral
data. The IR spectrum of compound 8 showed absorption
bands at 3420, 3280, 3190, 2240, and 1620 cm1 due to NH,
amino, cyano, and carbonyl groups, respectively. Meanwhile,
the IR spectrum of compound 9 showed the disappearance
of cyano group and presence of absorption bands at 3410,
3300 and 3200 cm1 for (NH2), (NH, NH2) groups and at
1600 cm1 for (CO). Also, the structure of compound 9 was
supported by its mass spectrum which, showed a molecular
ion peak at m/z= 285, (62.59%) which is in agreement with
its molecular formula (C13H11N5OS).
2-Carbohydrazide derivative (9) was used as a precursor for
synthesizing other new thienopyridazines and pyrimidothieno-
pyridazines. Thus, reﬂuxing of compound 9 with acetylacetone
in ethanol yielded a novel pyrazolyl derivative (10). Also, com-
pound 9 was reacted with ethyl acetoacetate in ethanol under
reﬂux to produce the thienopyridazine derivative (11) instead,
of the pyrazolone derivative (12). Treatment of compound 9
with nitrous acid at room temperature produced the carboaz-
ide derivative of compound 13, which underwent Curtius rear-
rangement followed by intramolecular cyclization upon
reﬂuxing in dry toluene to furnish imidazo[40,50:4,5]thie-
no[2,3-c]pyridazine (15) via the isocyanate intermediate (14)
(Scheme 4).
The structure of the new compounds 10, 11, 13 and 15 was
conﬁrmed on the basis of their elemental analyses and spectral
data. The IR spectra of compounds 10 and 11 revealed absorp-
tion bands at 3420–3400, 3290–3280 for amino group, and at
1680 cm1 due to carbonyl groups, respectively. The IR spec-
trum of compound 13 showed the characteristic band at
2120 cm1 due to the azido group, which disappeared in the
IR spectrum of compound 15.
The 1H NMR spectrum of compound 10 in (DMSO-d6)
showed two singlets at d 2.3, 2.6 ppm characteristic for two
methyls of pyrazole in addition to the expected signals attrib-
uted to amino, pyrazolo and aromatic protons. Also, the struc-
ture of compound 10 was supported by mass spectrum, which
showed a molecular ion peak at m/z= 349 (92.7%) that is in
agreement with its molecular formula (C18H15N5OS).
Furthermore, the interaction of compound 9 with some
reagents, namely acetic anhydride, formic acid, and triethylorthoformate produced the corresponding pyrimido[40,50:4,5]-
thieno[2,3-c]pyridazine derivatives (16–18), respectively
(Scheme 5). The structure of compounds 16–18 were conﬁrmed
based on elemental analyses and spectral data. The IR spectra
of compounds 16 and 17 showed absorption bands at 3300,
3270 for NH, at 1710 for carbonyl of acetyl, formyl and at
1675, 1660 cm1 for carbonyl of pyrimidinones, respectively.
Also, the IR spectrum of compound 18 showed an absorption
band at 1660 cm1 for the (CO, pyrimidinone).
4. Conclusion
In the present work, the synthesis of novel pyridazines (4, 5, 8),
thienopyridazines (6, 9–11, 13, 15), and pyrimidothienopyrida-
zines (16–18) is reported.. All spectroscopic analyses conﬁrmed
the proposed structures of these compounds. Antibacterial
780 A.S.N. Al-Kamali et al.activity data have shown that the synthesized compounds have a
signiﬁcant antibacterial activity against the tested
microorganisms.
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